Loading...
OTCMJRSS
Market cap12mUSD
Dec 19, Last price  
0.15USD
Name

JRsis Health Care Corp

Chart & Performance

D1W1MN
OTCM:JRSS chart
P/E
—
P/S
3.69
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
38.89%
Rev. gr., 5y
-34.36%
Revenues
3m
+3,782.57%
4,351,2365,979,61011,872,40318,118,74524,147,95728,402,75931,463,43335,706,19744,391,17189,1663,461,933
Net income
-81k
L-99.76%
399,977611,4941,790,7133,471,8684,646,8901,992,970888,0612,679,0952,232,261-33,721,300-80,912
CFO
517k
-83.15%
993,2142,054,1832,531,6394,986,4668,338,2109,199,13411,847,40310,643,0178,233,0163,066,645516,724

Profile

JRSIS Health Care Corporation provides a range of medical services in Harbin in the Heilongjiang Province of the People's Republic of China. The company offers services in the areas of pediatrics, dermatology, ears, nose, throat, traditional Chinese medicine, ophthalmology, internal medicine dentistry, general surgery, rehabilitation science, gynecology, general medical services, etc. It provides its services through Jiarun Hospital, which consists of 950 beds. The company was formerly known as China Runteng Medical Group Co., Ltd and changed its name to JRSIS Health Care Corporation in November 2013. JRSIS Health Care Corporation was founded in 2006 and is based in Harbin, the People's Republic of China.
URL
http://www.jhcc.cn/
IPO date
Mar 06, 2014
Employees
3
Domiciled in
CN
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
3,462
3,782.57%
89
-99.80%
44,391
24.32%
Cost of revenue
3,651
15,534
35,594
Unusual Expense (Income)
NOPBT
(189)
(15,445)
8,798
NOPBT Margin
19.82%
Operating Taxes
9
33,067,781
1,181
Tax Rate
13.43%
NOPAT
(198)
(33,083,226)
7,616
Net income
(81)
-99.76%
(33,721)
-1,610.63%
2,232
-16.68%
Dividends
Dividend yield
Proceeds from repurchase of equity
129
141
BB yield
Debt
Debt current
1,005
17
3,306
Long-term debt
28
20
44,673
Deferred revenue
Other long-term liabilities
7
Net debt
915
281
47,123
Cash flow
Cash from operating activities
517
3,067
8,233
CAPEX
(1)
(45)
(5,500)
Cash from investing activities
19
(2,828)
(5,500)
Cash from financing activities
(568)
(738)
(2,798)
FCF
61
(33,025,683)
(3,496)
Balance
Cash
118
59
856
Long term investments
(303)
Excess cash
Stockholders' equity
(3,315)
(23,651)
9,721
Invested Capital
4,184
24,407
56,985
ROIC
14.65%
ROCE
14.43%
EV
Common stock shares outstanding
77,253
61,334
18,662
Price
Market cap
EV
EBITDA
(131)
(15,426)
12,111
EV/EBITDA
Interest
56
1
1,382
Interest/NOPBT
15.71%